EXTRACELLULAR VESICLES-BASED BIOMARKERS FOR PANCREATIC CANCER

Methods and Reagent Kits for Diagnosing Canine Pancreatitis by Utilizing Acylcarnitines as Biomarkers

METABOLIC AND MICROBIAL BIOMARKERS FOR DETECTION OF PANCREATICOBILIARY CANCERS

IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER

METHOD OF DIAGNOSIS

Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer

Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer

Method and kit for the detection of pancreatic dysfunction

NON-INVASIVE APPROACH TO EARLY DIAGNOSIS AND PROGNOSIS OF ACUTE SEVERE PANCREATITIS BASED ON HEAT SHOCK PROTEINS MECHANISM OF ACTION

METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK FOR CHECKPOINT BLOCKADE THERAPY ASSOCIATED COLITIS

Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer

MARKERS FOR DISEASE AND DISEASE EXTENT IN INFLAMMATORY BOWEL DISEASE

USE OF THE RHO GDP DISSOCIATION INHIBITOR 2 PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INTESTINAL INFLAMMATORY DISEASES

Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer

Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

TARGETING OXAZOLE STRUCTURES FOR THERAPY AGAINST INFLAMMATORY DISEASES

Method for the diagnosis of acute pancreatitis (AP) by detection of glycoprotein 2 isoform alpha (GP2A)

Compositions and methods for measuring NMU and for treatment using anti-NMU agents

ATR-FTIR for non-invasive detection of colitis

Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis

Anti-pancreatic cancer monoclonal antibody and use thereof

Compositions and methods for reducing the risk of post-imaging pancreatitis

Method and kit for the detection of pancreatic dysfunction

Methods for treatment using anti-NMU agents

Multi-sensor array compound and methods of use thereof

PARALLEL ANALYSIS OF SERUM EPCAM AND MMP7 TO DISCRIMINATE SEPSIS, NECROTIZING ENTEROCOLITIS AND NORMAL CONTROL PATIENTS

Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils

Blood biomarkers for necrotizing enterocolitis

Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

ANTIBODIES TO CLOSTRIDIUM DIFFICILE SPORES AND USES THEREOF

Methods of treating pancreatitis

Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

Method of detecting pancreatic disease and pancreas testing kit

Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease

HMG1 antibody for treating inflammatory conditions

Methods for Diagnosing The Malignant Potential of Pancreatic Cystic Lesions

MATERIALS AND METHODS FOR THE DIFFERENTIAL DIAGNOSIS OF PACREATIC LESIONS

Methods and Compositions for Detecting Pancreatic Disease

Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy

Antibodies to spores and uses thereof

Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

GLYCOSYLATION MARKERS FOR PANCREATITIS, SEPSIS AND PANCREATIC CANCER

Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (GP2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis

HMG1 antibody for treating inflammatory conditions

Truncated PAP2 and methods of making and using same

Antagonists of HMG1 for treating inflammatory conditions

Adiponectin for treatment of various disorders

Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease

AGENT FOR PROPHYLAXIS AND TREATMENT OF PANCREATITIS

Chemokine panec-1 antibodies

Methods and Compositions for Detecting Pancreatic Disease

Chemokine PANEC-2 polypeptides and compositions and methods related thereto

Receptor

Antagonists of HMG1 for treating inflammatory conditions

Method for optimizing thiopurine efficacy and toxicity using mass spectrometry

Methods of diagnosing sepsis by measuring HMG1

Methods and devices for detecting pancreatic lipase